|
Plant Physiol. (1998) 118: 209-218
Piperonylic Acid, a Selective, Mechanism-Based Inactivator
of the trans-Cinnamate 4-Hydroxylase: A New Tool to Control
the Flux of Metabolites in the Phenylpropanoid Pathway1
Michel Schalk,
Francisco Cabello-Hurtado,
Marie-Agnès Pierrel,
Rossitza Atanossova,
Patrick Saindrenan, and
Danièle Werck-Reichhart*
Département d'Enzymologie Cellulaire et Moléculaire
(M.S., F.C.-H., D.W.-R.), and Département de Phytopathologie
(M.-A.P., R.A., P.S.), Institut de Biologie Moléculaire des
Plantes, Centre National de la Recherche Scientifique Unité
Propre de Recherche 406, 28 rue Goethe, 67000 Strasbourg, France
 |
ABSTRACT |
Piperonylic acid (PA) is a natural
molecule bearing a methylenedioxy function that closely mimics the
structure of trans-cinnamic acid. The CYP73A subfamily
of plant P450s catalyzes trans-cinnamic acid
4-hydroxylation, the second step of the general phenylpropanoid pathway. We show that when incubated in vitro with yeast-expressed CYP73A1, PA behaves as a potent mechanism-based and quasi-irreversible inactivator of trans-cinnamate 4-hydroxylase.
Inactivation requires NADPH, is time dependent and saturable
(KI = 17 µM,
kinact = 0.064 min 1), and
results from the formation of a stable metabolite-P450 complex
absorbing at 427 nm. The formation of this complex is reversible with
substrate or other strong ligands of the enzyme. In plant microsomes PA
seems to selectively inactivate the CYP73A P450 subpopulation. It does
not form detectable complexes with other recombinant plant P450
enzymes. In vivo PA induces a sharp decrease in 4-coumaric acid
concomitant to cinnamic acid accumulation in an elicited tobacco
(Nicotiana tabacum) cell suspension. It also strongly
decreases the formation of scopoletin in tobacco leaves infected with
tobacco mosaic virus.
 |
INTRODUCTION |
The phenylpropanoid metabolism is a plant-specific pathway leading
to compounds of extremely diverse structure and function (Dixon and
Paiva, 1995; Werck-Reichhart, 1995 ). It is involved in the formation of
quantitatively major biopolymers such as lignin and suberin, but also
in the biosynthesis of signaling molecules such as salicylic acid and
isoflavonoids in flower pigments, UV protectants such as anthocyanins,
flavonoids, and coumarins, and several classes of phytoalexins. The
upstream part of the phenylpropanoid metabolism, which branches from
the shikimate pathway at the level of L-Phe, consists of a
core of three enzymatic steps leading to 4-coumaroyl CoA (Fig.
1). This set of three reactions, often called the general phenylpropanoid pathway, controls the flux of
metabolites toward all families of compounds derived from the C6-C3
skeleton of Phe. Compounds with a C6-C1 structure are not strictly
phenylpropanoids, but also derive from L-Phe. They
originate from the core pathway intermediates cinnamic acid or
4-coumaric acid (Yalpani et al., 1993 ). Molecules with a C6-C1 backbone
include benzoic and salicylic acids and economically important
compounds such as vanillin.

View larger version (15K):
[in this window]
[in a new window]
| Figure 1.
Branching and inhibitors of the phenylpropanoid
pathway. AOPP, -Amino- -phenylpropionic acid; MDCA,
methylenedioxycinnamic acid.
|
|
The second step in the core phenylpropanoid pathway is the
hydroxylation of trans-cinnamic acid to 4-coumaric acid. The
reaction is catalyzed by C4H, a member of the superfamily of Cyt P450
heme-thiolate proteins. P450s are monooxygenases that catalyze the
oxidation of a remarkably broad range of endogenous and exogenous
chemicals in all organisms. In plants they play important roles in
biosynthetic pathways, including those of sterols, isoprenoids,
alkaloids, oxygenated fatty acids, and phenylpropanoids (Bolwell et
al., 1994 ; Durst and O'Keefe, 1995 ; Schuler, 1996 ). They are also
involved in the metabolism and sometimes in the activation of many
herbicides, insecticides, and other xenobiotics. CYP73A1 is a C4H from
Jerusalem artichoke (Helianthus tuberosus). Its coding
sequence was isolated from tuber tissues (Teutsch et al., 1993 ) and
expressed in yeast (Urban et al., 1994 ). The yeast-expressed enzyme is
catalytically active and capable of hydroxylating cinnamic acid with a
very high efficiency (kcat ranging from 100 to 400 min 1).
The high activity of the recombinant enzyme led us to investigate its
activity toward other potential substrates, natural plant components,
and xenobiotics. Several exogenous molecules were thus found to be
substrates of CYP73A1 (Pierrel et al., 1994 ; Schalk et al., 1997 ). The
efficiency of the metabolism of the xenobiotic molecules largely relied
on their structural analogy to the natural substrate. A systematic
structure-activity study recently led to the characterization of some
good alternative substrates and high-affinity inhibitors of the enzyme,
and of the structural requirements for an efficient binding into the active site of CYP73A1 (Schalk et al., 1997 ). The ideal ligand of C4H
was thus defined as a rigid hydrophobic backbone of the size of a
bicyclic aromatic structure (e.g. naphthalene), bearing one or several
small negatively charged substituent(s) centered around carbon 2 of the
naphthalene ring, the prototype alternative substrate being 2-naphthoic
acid (Fig. 2).
PA is a natural molecule extracted from the bark of the Paracoto tree
that roughly fulfills all of these requirements. PA contains a MDP
function at a position suitable for oxidative attack by CYP73A1. Many
compounds with MDP function have been shown to inhibit mammalian or
insect P450 enzymes both in vitro and in vivo (Franklin, 1977 ;
Wilkinson et al., 1984 ; Ortiz de Montellano and Correia, 1995 ). They
were shown to act as mechanism-based inactivators and to require
P450-catalyzed metabolism to generate a MI forming a stable complex
with the enzyme (Franklin, 1971 ). Available data suggest that the MI is
likely a carbene that binds as the sixth coordinant to the heme iron
(Mansuy et al., 1979 ).
We have tested PA inhibition of recombinant CYP73A1 and show that it
behaves as a very potent, mechanism-based inhibitor of C4H. It is
effective in vitro on the recombinant enzyme, being far more efficient
than other MDP compounds. It is apparently selective for C4H. Assays
performed in vivo on tobacco (Nicotiana tabacum) leaves and
cell cultures indicate that it can be used to inactivate C4H and to
block the input of precursors into the main C6-C3 pathway. To our
knowledge, it is the first selective and quasi-irreversible inhibitor
of the C4H so far described.
 |
MATERIALS AND METHODS |
Chemicals
All methylenedioxy compounds were from Aldrich. Scopoletin was
from Carl Roth GmbH (Karlsruhe, Germany). Ayapin was a gift of Dr.
Jesus Jorrín (Escuela Technica Superior Ingenieros Agronomica Montes, Córdoba, Spain). -Megaspermin was kindly provided by Dr. S. Kauffmann (Centre National de la Recherche Scientifique, UPR 406, Strasbourg, France).
trans-[3-14C]Cinnamic acid was from Isotopchim
(Ganagobie, France), [1-14C]lauric acid from Comissariat
à l'Energie Atomique (Gif-sur-Yvette, France), and
[1-14C]palmitic acid from DuPont-New England Nuclear. All
chemicals were of the highest purity available from commercial sources
and were used without further purification.
Yeast and Plant Microsomes
The Saccharomyces cerevisiae W303-1B strain (Mat
; ade2-1; his3-11,-15;
leu2-3,-112; ura3-1;
canR; cyr+), also
designated W(R), overexpressing its own NADPH-P450 reductase, was
constructed by Truan et al. (1993) . Plasmid C4H/V60, the
yeast-transformation procedure, and the preparation of yeast microsomes
were described by Urban et al. (1994) . Microsomes from the W(R) yeast
strain transformed with the void V60 plasmid were used as a negative control. Yeast microsomes expressing CYP51, CYP81B1, CYP76B1, or
CYP86A1 were prepared as described by Cabello-Hurtado et al. (1997 ,
1998a) , Batard et al. (1998) , and Benveniste et al. (1998) , respectively.
Microsomes were prepared from Jerusalem artichoke (Helianthus
tuberosus L. var. Blanc commun) tuber tissues that were sliced, aged, and treated with aminopyrine, MnCl2,
or CuCl2 as described previously (Werck-Reichhart et al., 1990 ; Cabello-Hurtado et al., 1998b ).
Spectrophotometric Measurements
Spectrophotometric measurement of total P450 content,
quantification of microsomal protein, measurement of binding spectra, and determination of the binding constants were performed as described previously (Gabriac et al., 1991 ).
Enzymatic Assays
The assay of C4H activity with radiolabeled
trans-cinnamic acid as the substrate was described by
Reichhart et al. (1980) . Possible PA reaction products were analyzed by
reverse-phase HPLC on an instrument (model 510, Waters) equipped with
an absorbance detector (model 480, Waters). Separations were performed
on a C18 5 µ 100 × 4.6 mm Brownlee
column using a mobile phase consisting of aqueous acetonitrile
containing 0.1% acetic acid at a flow rate of 1 mL
min 1. Kinetic data were fitted using the
nonlinear regression program DNRPEASY derived by Duggleby (1984)
from DNRP53.
Enzyme Inactivation
The time-dependent inhibition of the C4H activity in transformed
yeast microsomes was investigated using a general dilution procedure
(Silverman, 1996 ). Yeast microsomes (400 nM CYP73A1) were
preincubated at 30°C in 0.1 M sodium phosphate, pH 7.4, 50 µM NADPH, 1 mM Glc-6-P, and 1 unit
mL 1 Glc-6-P dehydrogenase with 0 to 20 µM PA. At timed intervals, aliquots were diluted 20-fold
into a second incubation mixture containing radiolabeled cinnamic
acid (200 µM) to assay residual activity. PA
concentrations and preincubation times were chosen in accordance with
the results of binding experiments shown in Figure
3 to be pseudo-first-order and not
saturating conditions.

View larger version (26K):
[in this window]
[in a new window]
| Figure 3.
Binding of PA to CYP73A1. Difference spectra were
recorded in 0.1 M sodium phosphate, pH 7.4, containing
CYP73A1 (0.12 µM) in microsomes from transformed W(R)
yeast. Solid lines correspond to the difference spectra obtained after
addition of increasing amounts (5, 10, 30, 80, 180, and 380 µM) of PA to the sample cuvette (curves a-f). An equal
volume of buffer was added to the reference. The broken line is the
difference spectrum obtained under the same conditions after addition
of 100 µM cinnamic acid. Inset, Double-reciprocal plot of
A412-430 versus PA concentration.
|
|
Treatments of Leaf Tissues and Tobacco (Nicotiana
tabacum L. cv Samsun, NN) Cell Suspension
Three-week-old tobacco plants were inoculated on the uppermost
fully expanded leaves with TMV. Leaves were syringe infiltrated with
water or 500 µM PA 16 h after inoculation with TMV.
Infiltrated tissues were collected 3 d after inoculation, frozen
in liquid nitrogen, and stored at 80°C before analysis.
The tobacco BY-2 cell suspension was maintained as described by Nagata
et al. (1992) . Synchronization of the cells was achieved according to
the method of Reichheld et al. (1995) with 3 mg
mL 1 aphidicolin and 1.5 mg
mL 1 propyzamide. Elicitor treatment of
cell-suspension cultures was performed 48 h after aphidicolin
treatment with 50 nM -megaspermin, an elicitin protein
purified from culture filtrates of Phytophthora megasperma
(Baillieul et al., 1995 ). PA (100 µM) was added at the
same time as megaspermin. Cells were harvested by vacuum filtration 13 h after treatment, and frozen in liquid nitrogen.
Analytical Procedures
Tissue samples (0.5 g) and frozen cells (0.2-0.3 g) were
extracted using a protocol described by Bailleul et al. (1995).
Scopoletin content was determined by on-line UV absorption and
fluorescence detection after separation on a C18
reverse-phase column (Dorey et al., 1997 ). Total cinnamic and
4-coumaric acids extracted after acid hydrolysis were first separated
by chromatography on plates (Silicagel 60F254, Merck) developed with
toluene-acetic acid-water (6:7:3, v/v, organic phase). 4-Coumaric
(RF 0.37) and cinnamic acids (RF 0.62) were
scraped and eluted with MeOH. Eluates were further analyzed and
quantified on a C18 reverse-phase column by HPLC
using a photodiode array detector (model 996, Waters). Samples were
eluted with a gradient of increasing solvent B (acetonitrile) in
solvent A (25 mM
NaH2PO4 adjusted to pH 3.0 with phosphoric acid): 0 to 5 min, 5% B; 5 to 20 min, 5% to 20% B;
and 20 to 26 min, 20% to 80% B. The A290
and A280 of the eluate were monitored for
quantification of cinnamic and 4-coumaric acids, respectively. Retention times and calibration curves were established with authentic samples.
 |
RESULTS |
Binding of PA to CYP73A1
A shift in the Soret maximum from 420 to about 390 nm is usually
observed upon addition of substrates to oxidized native P450s (Jefcoate, 1978 ). The resulting difference spectrum is referred to as
type I. The type I spectrum reflects the increase in the high-spin
character of the iron, which is a consequence of the displacement of
water bound as sixth iron ligand on the distal face of the heme (Fisher
and Sligar, 1987; Helms et al., 1996 ).
Binding of trans-cinnamic acid to CYP73A1 results in a
typical type I spectrum (Fig. 3). Addition of PA to a microsomal
suspension of W(R) yeast expressing CYP73A1 also induced a shift in
absorbance that clearly resulted from its binding in the P450 heme
pocket (Fig. 3). The oxidized and PA-bound versus oxidized difference spectrum presented a peak at about 412 nm and a trough around 430 nm.
The A412 430 increased with
PA concentration and saturation was obtained at a concentration of
about 400 µM. The apparent Ks
calculated from the double-reciprocal plot of
A412 430 versus substrate
concentration was 45 ± 11 µM. The PA-induced spectrum was reminiscent of but not identical to the spectrum induced
by cinnamic acid. The shift of the Soret maximum to 412 nm in the
CYP73A1-PA complex possibly indicates a PA-induced alteration in the
heme-protein structure or a direct interaction of PA with the
iron-porphyrin system. The small amplitude of the absorbance change
also suggests that the solvent was not completely displaced from the
immediate heme environment.
Formation of a CYP73A1-MI Complex
A typical difference spectrum showing a dual Soret absorption and
usually referred to as type III was obtained upon metabolism of MDP
compounds by animal P450s (Hodgson et al., 1973 ). In the presence of
NADPH the PA-binding spectrum previously observed evolved in a
time-dependent manner into a spectrum showing two distinct peaks (Fig.
4), one at 455 nm, which appeared
immediately and decreased upon incubation, and a second, much sharper
peak at 427 nm, which increased rapidly in the first few minutes of incubation. The change in absorbance was dependent on NADPH and time of
incubation. It was not observed with control microsomes prepared from
yeast transformed with a void plasmid.

View larger version (24K):
[in this window]
[in a new window]
| Figure 4.
Formation of a complex between the CYP73A1 and PA
metabolite. CYP73A1 (0.12 µM) in transformed yeast
microsomes was incubated at 30°C in 0.1 M sodium
phosphate buffer, pH 7.4, containing 500 µM NADPH. PA was
added to the sample cuvette at a final concentration of 30 µM. Difference spectra were recorded 1, 2, 3, 4, 5, 7, and 10 min after adding PA (curves a-g).
|
|
The increase in A427 490 was
recorded as a function of time for various concentrations of PA (Fig.
5). It displayed saturation kinetics as a
function of both time and PA concentration. After 15 to 30 min of
incubation, the amplitude of
A427 490 started to decline
slowly. This was likely the result of a reoxidation of CYP73A1
(Franklin, 1971 ), since both formation and stability of the complex
absorbing at 427 nm were enhanced by reduction of heme iron. The
addition of sodium dithionite to both cuvettes after completion of the
reaction with NADPH resulted in a slight increase in
A427 and in a complete disappearance of the
peak at A455. After complete reduction, the
spectrum remained quite stable. A similar stabilization of the P450
complex by subsequent addition of sodium dithionite was observed with
several MDP compounds (Hodgson et al., 1973 ; Yu et al., 1980 ).

View larger version (21K):
[in this window]
[in a new window]
| Figure 5.
Time- and inhibitor-concentration-dependence
of the formation of the complex between CYP73A1 and PA. Formation of
the complex was measured as described in Figure 4. Time-dependent
appearance of the 427-nm peak was recorded for PA concentrations of 2 (  ), 5 (- - -), 15 ( · - · ), 30 (- - -), and 50 µM ( · · · - · · · ).
|
|
The 427-nm-absorbing species was not formed with sodium dithionite
alone. Metabolic activation of PA is thus required, and the type III
spectrum does not result from the direct binding of PA to reduced P450.
These data strongly suggest that the absorbance changes observed in the
presence of PA and NADPH actually reflect the formation of a P450-bound
MI.
Reversibility of the P450-MI Complex
The animal P450-MI complexes were reported to be reversible by
type I ligands (Elcombe et al., 1975; Dickins et al., 1979 ), but not by
CO (Hodgson and Philpot, 1974). A reversion of the CYP73A1-MI complex
by the substrate was also detected by differential spectrophotometry.
CYP73A1 in yeast microsomes was incubated with NADPH in both cuvettes
and PA in the sample. After 10 min (i.e. completion of the reaction), a
baseline between the two cuvettes was recorded. The subsequent addition
of cinnamic acid (100 µM) to both cuvettes resulted in
the time-dependent formation of a trough at 427 nm. The initial type
III spectrum could be totally reversed (i.e. the trough reached the
same amplitude as the peak previously observed), but the reversion was
much slower than the formation of the complex, lasting 60 instead of 10 min (not shown). The complex was also efficiently reversed by
2-hydroxy-1-naphthoic acid, a high-affinity ligand and competitive
inhibitor of CYP73A1 (Schalk et al., 1997 ).
Addition of CO to the sample cuvette after stabilization of the complex
with sodium dithionite did not shift the absorption to 450 nm. The
P450-MI complex was thus not dissociated by CO (not shown), in
agreement with previous reports (Hodgson et al., 1973 ).
Kinetics of CYP73A1 Inactivation by PA
To confirm mechanism-dependent inactivation, CYP73A1
in a yeast microsomal suspension was preincubated with PA and
NADPH before measurement of C4H residual activity. Pseudo-first-order
kinetics were observed for the initial phase of the inactivation (Fig. 6). Inactivation rates increased with PA
concentration. Despite a 20-fold dilution of the preincubation medium
before the measurement of residual activity, coordinate intercepts
reflect a significant competitive inhibition and confirm that PA binds
to the same site as cinnamic acid. The plot of the estimated half-life
for inactivation (t1/2) at each PA
concentration compared with the 1/PA concentration is characteristic of
an inactivation that proceeds with saturation (Silverman, 1996 ). The
kinetic constants calculated from the plot are
KI = 17 µM and
kinact = 0.064 min 1.

View larger version (29K):
[in this window]
[in a new window]
| Figure 6.
Time- and concentration-dependent inactivation of
CYP73A1 by PA. CYP73A1 in W(R) yeast microsomes was preincubated at
30°C in 0.1 M sodium phosphate, pH 7.4, with 50 µM NADPH, 1 mM Glc-6-P, 0.2 unit of Glc-6-P
dehydrogenase, and 0 ( ), 3 ( ), 5 ( ), 10 ( ), and 20 µM ( ) PA. The residual C4H activity was then assayed
as described in ``Materials and Methods''. Data correspond to means
of duplicates. Inset, Times of one-half inactivation
(t1/2) estimated from linear regression
analysis were plotted against the reciprocal of PA concentration.
|
|
Other Methylenedioxy Compounds
MDP compounds are widely used to characterize P450-dependent
reactions, and are often considered to be broad-specifity inhibitors of
P450 enzymes. Therefore, we tested and compared the inhibition of C4H
obtained with a set of different MDP compounds, some of them showing
structural similarity to cinnamic acid, to that obtained with PA. The
MDP compounds tested widely differ in the size and nature of their side
chains (Table I). Several of these
compounds have previously been reported to inhibit insect or animal
enzymes (Hodgson and Philpot, 1974). Ayapin is a natural coumarin
synthesized by H. tuberosus in response to elicitation or
pathogen attack (Gutiérrez-Mellado et al., 1996 ; Cabello-Hurtado
et al., 1998b ). Its reported fungicidal effect (Tal and Robeson, 1986 )
probably relies on its methylenedioxy function. Residual C4H activity
was assayed in yeast microsomes after 15 min of preincubation with each
compound (100 µM) in the presence of NADPH. Table I shows that PA is by far the most effective inhibitor of CYP73A1. The second
most efficient molecule is another analog of cinnamic acid, 3,4-(methylenedioxy)phenyl acetic acid. Ayapin also produces a significant inactivation. The 3,4-methylenedioxy derivative of cinnamic
acid, which is commonly used as an inhibitor of the coumaroyl-CoA ligase (Funk and Brodelius, 1990 ), is a very poor inhibitor of C4H.
View this table:
[in this window]
[in a new window]
|
Table I.
Inactivation of CYP73A1 by methylenedioxy compounds
CYP73A1 in transformed yeast microsomes were preincubated at a
concentration of 250 nM with 4 mM Glc-6-P, 0.1 unit of Glc-6-P dehydrogenase, 100 µM NADPH, and 100 µM of each inhibitor. After 15 min, 10 µL of the
mixture was transferred into the C4H assay for determination of
residual activity. The assay contained 4 mM Glc-6-P, 0.1 unit of Glc-6-P dehydrogenase, 100 µM NADPH, and 100 µM radiolabeled trans-cinnamic acid in a final
volume of 200 µL. 4-Coumaric acid formed after 3 min of incubation
was determined as described previously (Reichhart et al., 1980 ).
|
|
Selectivity of PA toward C4H
The efficiency of PA as a mechanism-based inhibitor of C4H seems
to largely rely on its high structural homology to cinnamic acid.
However, the MDP function can potentially inactivate any P450 enzyme.
To determine if PA was selective for C4H or if it also inactivated
other P450s, we made an estimation of the proportion of P450 converted
into the MI complex and compared it with the proportion of C4H in total
plant microsomes. No PA metabolite was detected by HPLC analysis of the
incubation medium, suggesting that no metabolite leaves the active site
of the P450(s) that catalyzes its activation and binds other P450
enzymes. The amount of P450-MI complex determined by spectrophotometry
can thus be used to measure the proportion of total P450 capable of
metabolizing PA in a mixture such as that in plant microsomes.
A similar approach was proposed by Franklin (1991) to determine the
proportion of P450 isozymes capable of oxidatively metabolizing macrolide antibiotics to a nitroso intermediate in liver microsomes. To
determine an extinction coefficient ( ) for the Soret maximum of the
reduced CYP73A1-MI complex, we measured
A427 490 for several
dilutions of yeast microsomes (i.e. 30-150 nM CYP73A1) after 15 min of incubation with 50 µM PA and a
NADPH-regenerating system and subsequent complete reduction with sodium
dithionite. A427 490 was
proportional to the CYP73A1 content of the incubation medium: the
427 490 was 102 mM 1 cm 1.
This extinction coefficient was then used to determine the P450-MI content (Table II) in microsomes of
Jerusalem artichoke tubers treated to modify P450 enzyme subpopulations
(Batard et al., 1995 , 1997; Cabello-Hurtado et al., 1998b ). CYP73A1
contents were determined in the same microsomes from the
substrate-binding spectra (Urban et al., 1994 ). The difference spectra
observed upon incubation of plant microsomes with PA and NADPH were
identical to those obtained with recombinant CYP73A1. Table II shows
that the C4H contents deduced from substrate binding were very similar
to the content of P450-MI complexes measured in the same microsomes. Only the results obtained with microsomes prepared from
aminopyrine-treated tissues suggested the possible existence of another
P450 subspecies able to form a MI complex with PA.
View this table:
[in this window]
[in a new window]
|
Table II.
Determination of the amounts of CYP73A1-MI complex
formed in Jerusalem artichoke tuber microsomes after incubation with PA
Microsomes were prepared from tuber tissues, sliced, and aged for
24 h in water (wounding) or 1 mM CuCl2,
for 48 h in 20 mM aminopyrine, or for 72 h in 25 mM MnCl2, pH 7.0. All measurements were
performed by differential spectrophotometry. Microsomes were diluted in
0.1 M sodium phosphate buffer, pH 7.4. Total P450 content
was estimated from the reduced-CO binding spectra according to the
method of Omura and Sato (1964) . The C4H content was estimated from
trans-cinnamic acid binding to native microsomes as
previously described (Urban et al, 1994 ). The MI complex was quantified
as described in ``Results''. All values are means of triplicates.
|
|
To further confirm the selectivity of PA, we tested if other available
yeast-expressed plant P450 enzymes, CYP81B1 and CYP76B1 from Jerusalem
artichoke, CYP51 from wheat, and CYP86A1 from Arabidopsis, were able to
form MI complexes with PA. No MI-complex formation was detected when
yeast microsomes containing from 68 to 125 pmol mg 1 protein of either P450 were incubated for
15 min with concentrations up to 100 µM PA (data not
shown).
Effect of PA on the Phenylpropanoid Metabolism in Vivo
PA seems to be a potent and selective inhibitor of C4H in vitro.
The in vivo activity of the molecule could be limited by a low
permeability of the plant tissues or by a fast metabolism of the
compound. We therefore tested the effects of PA on the accumulation of
some phenylpropanoid intermediates in induced plant cells or leaf
tissues.
A BY2 tobacco cell suspension was simultaneously elicited with
-megaspermin and given 100 µM PA. The cinnamic and
4-coumaric acid contents of the cells were determined 13 h after
the beginning of the treatment (Fig. 7).
The sharp decrease in 4-coumaric acid (13-fold), together with the
strong cinnamic acid accumulation (20-fold) observed relative to
control cells treated with elicitor alone, were consistent with an
effective inhibition of C4H.

View larger version (28K):
[in this window]
[in a new window]
| Figure 7.
Effect of PA treatment on cinnamic and 4-coumaric
acids concentrations in elicited tobacco cells. A synchronized BY2
tobacco cell suspension was treated with 50 nm -megaspermin, alone
or together with 100 µM PA. Total cell contents in
cinnamic and 4-coumaric acids (free plus conjugated forms) were
determined after 13 h of treatment, as described in ``Materials and Methods''.
|
|
Scopoletin is a simple 7-hydroxylated coumarin. Its biosynthetic
pathway is not elucidated, but involves at least the first two steps of
the core phenylpropanoid pathway (Fritig et al., 1970 ). Scopoletin
accumulation is observed in cultured tobacco cells in response to
fungal elicitor. In tobacco leaves scopoletin is responsible for the
fluorescent rings observed around local lesions occurring in the
hypersensitive response to TMV. When plant cells were treated
simultaneously with -megaspermin and PA, scopoletin accumulation was
considerably decreased compared with cells treated with -megaspermin
alone (Table III). A similar effect was
observed when 500 µM PA was injected in TMV-infected tobacco leaves. Scopoletin accumulation measured after 3 d was decreased by about 70% compared with leaves injected with water (Table
III).
View this table:
[in this window]
[in a new window]
|
Table III.
Effect of PA on the induced accumulation of
scopoletin in plant cells or tissues
Synchronized BY2 tobacco cell suspensions were treated with 50 nM -megaspermin, alone ( PA) or together with 100 µM PA (+PA). The scopoletin content of the cells was
analyzed 13 h after treatment. Tobacco leaves were syringe
infiltrated with water or 500 µM PA 16 h after
inoculation with TMV. Scopoletin content of the tissues was determined
3 d after inoculation. Results are given in relative units
compared with controls without elicitor treatment or TMV inoculation.
Scopoletin contents in control cells and tissues were 0.11 and 0.12 µg g 1 fresh weight, respectively.
|
|
 |
DISCUSSION |
Based on a structure-activity study we have recently characterized
strong competitive inhibitors of C4H (Schalk et al., 1997 ). Mechanism-based inactivators are potentially more efficient and selective, since (a) they must satisfy the structural constraints imposed for binding to the active site, (b) the inhibitor must be
acceptable as a substrate for its catalytical activation, and (c)
reactive species produced by catalysis irreversibly or
quasi-irreversibly alter the enzyme and remove it permanently or
quasi-permanently from the catalytic pool (Ortiz de Montellano and
Correia, 1995 ).
First used empirically as herbicide synergists or drug potentiators,
MDP compounds have subsequently been shown to exert their activity via
mechanism-based inactivation of xenobiotic-metabolizing P450 enzymes.
The inhibition of P450 activities by MDP compounds and the
mechanism-based formation of MI complexes have been extensively studied
in a number of species both in vitro and in vivo and found to affect a
broad range of P450-dependent reactions (Franklin, 1971 ; Hodgson and
Philpot, 1974; Elcombe et al., 1975). Inhibition of P450 by MDP
compounds has also been observed in plant tissues (Varsano et al.,
1992 ; Kusukawa et al., 1995 ). It is generally accepted that the P450
inactivation and the unusual optical absorption spectra observed with
inactivated enzymes result from the direct interaction with heme iron
of a carbene formed by hydrogen abstraction or by elimination of water
from a hydroxymethylene intermediate.
The strong -acceptor character of the carbene explains the shift of
the Soret peak toward long-absorption wavelengths and the stability of
the complex that is not displaced by CO or dioxygen (Wilkinson et al.,
1984 ). MDP-P450 complexes are preserved through microsome extraction,
dialysis, detergent treatment (Elcombe et al., 1975), oxidation, and
re-reduction of the enzyme (Franklin, 1979). Inactivation, however, is
not completely irreversible since the carbene can be displaced by
type-I ligands (i.e. substrates), in particular once the enzyme is
re-oxidized. There is a considerable degree of selectivity in the
inhibitory potency of the MDP compounds toward different P450 enzymes
(Wilkinson et al., 1984 ; Murray et al., 1993 ). The interactions of MDP
side chains and aromatic cycles with the protein regions adjacent to
the heme determine not only the binding of the compound prior to
metabolism, but also the stability and further transformation of the
complex.
In vitro, PA shows all of the characteristics of a specific ligand and
of a very potent mechanism-based inactivator of C4H. The totality of
the recombinant enzyme is complexed after less than 10 min in the
presence of 30 µM PA, with a quasi-total loss in
catalytic activity. Inactivation and formation of the MI complex are
observed only in the presence of NADPH, increase in a time-dependent manner, and exhibit saturation kinetics. The presence of substrate or
competitive inhibitors slows down or completely reverses the formation
of the complex. This reversion process is, however, slow compared with
inactivation and requires high, most likely nonphysiological,
substrate concentrations.
The optical difference spectrum resulting from incubation of CYP73A1
with PA in the presence of NADPH is typical of a P450-MDP metabolite
interaction (Wilkinson et al., 1984 ). This spectrum differs slightly
from the typical type-III spectrum observed with the majority of MDP
derivatives, since the peak at 455 nm appears only very transiently.
The two peaks detected in the MI-bound versus free-P450 difference
spectra are thought to reflect the formation of two distinct types of
MI-P450 complexes, but the exact nature of the two complexes has not
been elucidated. The 455-nm peak is usually considered to reflect only
the interaction of the carbene with heme iron. Conversion of the
455-nm-absorbing entity into a 427-nm-absorbing complex seems to depend
both on the substituents of the MDP molecules and on the P450 isoform that metabolizes it.
It has been proposed that the 427-nm peak could result from
interactions of the MDP side chains with the protein in the vicinity of
heme or from a shift in the spin state of the heme iron. The most
plausible explanation, however, seems to be a rupture of the bond
between heme iron and its Cys thiolate fifth ligand (Dahl and Hodgson,
1979 ; Wilkinson et al., 1984 ). It can be speculated that this rupture
results from a stretching of the iron-sulfur bond induced by the
electron-withdrawing properties of MDP substituants or by the
interactions of the MDP side chains with the protein. An increase in
the iron-sulfur distance upon CO binding has been demonstrated for
P450cam (Raag and Poulos, 1989 ). In addition, the
strong electrostatic interactions that are likely to ensure PA binding
to the apoprotein and the shortened ring structure of the molecule
compared with an ideal substrate (Fig. 2) would support the hypothesis
of a very stretched complex. It has been reported that the presence of
electron-withdrawing substituants on the MDP aromatic ring tends to
favor the production of CO from the methylenic carbon of the
methylenedioxy ring (Yu et al., 1980 ), leading to the formation of a
typical complex absorbing at 450 nm. It is interesting to note that
despite the presence of a carboxylic function on PA, no formation of a
CYP73A1-CO complex was detected.
Its close structural analogy to the natural substrate seems to confer
on PA a real selectivity for C4H. None of the other plant P450s that we
tested so far, which were reported as fatty acid hydroxylases or sterol
or 7-ethoxycoumarin O-dealkylases, were capable of forming
spectrally detectable complexes that would indicate enzyme
inactivation. PA was also apparently selective for C4H in microsomes
from Jerusalem artichoke. However, the potential number of P450s in
plant tissues is extremely high. In the phenylpropanoid pathway alone,
more than 16 P450-dependent reactions have been characterized, and more
than 120 plant P450 genes have already been isolated. C4H is very
abundant in plants, as shown in Jerusalem artichoke tissues (Table II).
Formation of a MI complex with a minor P450 subpopulation in plant
microsomes would not be detectable by the spectrophotometric approach
used in this work. It is thus reasonable to assume that PA is not
strictly specific to C4H, although inactivation of another P450 isoform
with a similar efficiency is highly improbable.
PA also seems to be an efficient inactivator of C4H in vivo, blocking
the synthesis of 4-coumaric acid and inducing the accumulation of
cinnamic acid in plant cells. Tools were already available to block the
steps upstream and downstream in the pathway (Fig. 1).
-Aminooxy- -phenylpropionic acid, which inhibits Phe-ammonia lyase, has been available and used extensively for many years to block
the whole phenylpropanoid pathway (Amrhein and Gödeke, 1977 ).
3,4-(Methylenedioxy)-cinnamic acid has recently been described as a
potent inhibitor of the coumaroyl CoA-ligase (Funk and Brodelius, 1990 ). This compound, which also bears a methylenedioxy function and is
a structural analog of cinnamic acid, does not affect C4H. We have
previously shown that size and charge are critical determinants in the
binding of ligands into the substrate pocket of CYP73A1 (Schalk et al.,
1997 ). This is confirmed by the data presented in Table I. It is thus
probable that the methylenedioxy ring renders the molecule too large to
bind or to have access to the active site of C4H. MDCA remains a
potential inhibitor of other P450 enzymes downstream in the pathway.
Compared with aminooxy- -phenylpropionic acid and
3,4-(methylenedioxy)-cinnamic acid, PA offers new potential
applications. It can be used to selectively block the C6-C3 metabolism
and, possibly, to shift the precursor flow into the formation of C6-C1 compounds such as benzoic and salicylic acids. It also offers a
possibility to determine if 4-hydroxybenzoic acids derive from cinnamic
acid or must be formed from 4-hydroxycinnamic acids. Many reports
(Werck-Reichhart, 1995 ; Sewalt et al., 1997 ) have suggested that C4H,
possibly via its product and substrate, has a regulatory function in
the coordinate regulation of the phenypropanoid pathway. PA is a new
tool to test this hypothesis.
 |
FOOTNOTES |
1
This work was supported by a Ministére de
la Recherche et de l'Enseignement Supériur grant to M.S.
F.C.-H. was supported by a postdoctoral grant from the Spanish
Ministerio de Agricultura, Pesca y Alimentación, and M.-A.P. was
supported by the Bio Avenir program funded by Rhône-Poulenc, the
Ministère de la Recherche et de l'Espace, and the
Ministère de l'Industrie et du Commerce Extérieur.
*
Corresponding author; e-mail daniele.werck{at}ibmp-ulp.u-strasbg.fr;
fax 33-3-88-35-84-84.
Received February 17, 1998;
accepted May 21, 1998.
 |
ABBREVIATIONS |
Abbreviations:
C4H, trans-cinnamate
4-hydroxylase (NADPH:oxygen oxidoreductase [4-hydroxylating] EC
1.14.13.11) .
MDP, methylenedioxyphenyl.
MI, metabolic intermediate.
PA, piperonylic acid.
TMV, tobacco mosaic virus.
 |
ACKNOWLEDGMENTS |
We thank Drs. D. Pompon and P. Urban for providing the W(R)
yeast strain and the pYeV60 expression vector and Dr. I. Benveniste for
microsomes of yeast expressing CYP86A1. We also thank M.F. Castaldi for
her technical assistance. The critical reading of the manuscript by F. Bernier and R. Kahn is gratefully acknowledged.
 |
LITERATURE CITED |
Amrhein N,
Gödeke KH
(1977)
Plant Sci Lett
8:
313-317
[CrossRef]
Baillieul F,
Genetet I,
Kopp M,
Saindrenan P,
Fritig B,
Kauffmann S
(1995)
A new elicitor of the hypersensitive response in tobacco: a fungal glycoprotein elicits cell death, expression of defence genes, production of salicylic acid, and induction of systemic acquired resistance.
Plant J
8:
551-560
[CrossRef][ISI][Medline]
Batard Y,
LeRet M,
Schalk M,
Robineau T,
Durst F,
Werck-Reichhart D
(1998)
Plant J
14:
111-120
[CrossRef][Medline]
Batard Y,
Zimmerlin A,
Le Ret M,
Durst F,
Werck-Reichhart D
(1995)
Multiple xenobiotic-inducible P450s are involved in alkoxycoumarins and alkoxyresorufins metabolism in higher plants.
Plant Cell Environ
18:
523-533
[CrossRef]
Benveniste I,
Tijet N,
Adas F,
Philips G,
Salaun JP,
Durst F
(1998)
CYP86A1 from Arabidopsis thaliana encodes a cytochrome P450-dependent fatty acid omega-hydroxylase.
Biochim Biophys Res Commun
243:
688-693
[CrossRef][ISI][Medline]
Bolwell GP,
Bozak K,
Zimmerlin A
(1994)
Plant cytochrome P450.
Phytochemistry
37:
1491-1506
[CrossRef][ISI][Medline]
Cabello-Hurtado F,
Batard Y,
Salaün JP,
Durst F,
Pinot F,
Werck-Reichhart D
(1998a)
Cloning, expression in yeast and functional characterization of CYP81B1, a plant P450 which catalyzes in-chain hydroxylation of fatty acids.
J Biol Chem
273:
7260-7267
[Abstract/Free Full Text]
Cabello-Hurtado F, Durst F, Jorrin JV, Werck-Reichhart, D (1998b)
Coumarins in Helianthus tuberosus: characterization, induced
accumulation and biosynthesis. Phytochemistry (in press)
Cabello-Hurtado F,
Zimmerlin A,
Rahier A,
Taton M,
DeRose R,
Nedelkina S,
Batard Y,
Durst F,
Pallett KE,
Werck-Reichhart D
(1997)
Cloning and functional expression in yeast of a cDNA coding for an obtusifoliol 14 -demethylase (CYP51) in wheat.
Biochem Biophys Res Commun
230:
381-385
[CrossRef][ISI][Medline]
Dahl AR,
Hodgson E
(1979)
The interaction of aliphatic analogs of methylenedioxyphenyl compounds with cytochrome P-450 and P-420.
Chem Biol Interact
27:
163-175
[CrossRef][ISI][Medline]
Dickins M,
Elcombe CR,
Moloney SJ,
Netter KJ,
Bridges JW
(1979)
Further studies on the dissociation of the isosafrole metabolite-cytochrome P450 complex.
Biochem Pharmacol
28:
231-238
[Medline]
Dixon RA,
Paiva N,
L
(1995)
Stress-induced phenylpropanoid metabolism.
Plant Cell
7:
1085-1097
[CrossRef][ISI][Medline]
Dorey S,
Baillieul F,
Pierrel M,
A,
Saindrenan P,
Fritig B,
Kauffmann S
(1997)
Spatial and temporal induction of cell death, defense genes, and accumulation of salicylic acid in tobacco leaves reacting hypersensitively to a fungal glycoprotein elicitor.
Mol Plant-Microbe Interact
10:
646-655
[CrossRef][ISI]
Duggleby RG
(1984)
Regression analysis of nonlinear Arrhenius plots: an empirical model and a computer program.
Comput Biol Med
14:
447-455
[CrossRef][Medline]
Durst F,
O'Keefe D
(1995)
Plant cytochromes P450s: an overview.
Drug Metab Drug Interact
12:
171-187
[Medline]
Elcombe CR, Bridges JW, Gray TJB, Ninno-Smith RH, Netter KJ.
(1975) Studies on the interaction of safrole with rat hepatic
microsomes. Biochem Pharmacol 24: 1427-1433
Fischer MT,
Sligar SG
(1987)
Temperature jump relaxation kinetics of the P450cam spin equilibrium.
Biochemistry
26:
4797-4803
[CrossRef][Medline]
Franklin MR
(1971)
The enzymic formation of a methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P450 in hepatic microsomes.
Xenobiotica
1:
581-591
[Medline]
Franklin MR
(1977)
Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes.
Pharmacol Ther A
2:
227-245
Franklin MR
(1991)
Cytochrome P450 metabolic intermediate complexes from macrolide antibiotics and related compounds.
Methods Enzymol
206:
559-573
[ISI][Medline]
Fritig B,
Hirth L,
Ourisson G
(1970)
Biosynthesis of the coumarins: scopoletin formation in tobacco tissue cultures.
Phytochemistry
9:
1963-1975
[CrossRef]
Funk C,
Brodelius PE
(1990)
Phenylpropanoid metabolism in suspension cultures of Vanillia planifolia Andr. II. Effects of precursor feeding and metabolic inhibitors.
Plant Physiol
94:
95-101
[Abstract/Free Full Text]
Gabriac B,
Werck-Reichhart D,
Teusch H,
Durst F
(1991)
Purification and immunocharacterisation of a plant cytochrome P450: the cinnamic acid 4-hydroxylase.
Arch Biochem Biophys
288:
302-309
[CrossRef][Medline]
Gutiérrez-Mellado MC,
Edwards R,
Tena M,
Cabello F,
Serghini K,
Jorrin J
(1996)
The production of coumarin phytoalexins in different plant organs of sunflower (Helianthus annuus L.).
J Plant Physiol
149:
261-266
[ISI]
Helms V,
Deprez E,
Gill E,
Barret C,
Hui Bon Hoa G,
Wade RC
(1996)
Improved binding of cytochrome P450cam substrate analogues designed to fill extra space in the substrate binding pocket.
Biochemistry
35:
1485-1499
[CrossRef][Medline]
Hodgson E,
Philipot RM
(1974)
Interaction of methylenedioxyphenyl (1,3-benzodioxole) compounds with enzymes and their effects on mammals.
Drug Metab Rev
3:
231-301
[ISI][Medline]
Hodgson E,
Philpot RM,
Baker RC,
Mailman RB
(1973)
Effect of synergists on drug metabolism.
Drug Metab Dispos
1:
391-401
[Medline]
Jefcoate CR
(1978)
Measurement of substrate and inhibitor binding to microsomal cytochrome P450 by optical-difference spectroscopy.
Methods Enzymol
52:
258-279
[Medline]
Kusukawa M,
Iwamura H
(1995)
N-(3,4-Methylendioxyphenyl) carbamates as potent flowering-inducing compounds in Asparagus seedlings as well as probes for binding to cytochrome P450.
Z Naturforsch
50c:
373-379
Mansuy D,
Battioni JP,
Chottard JC,
Ullrich V
(1979)
Preparation of a porphyrin-iron-carbene model for the cytochrome P450 complexes obtained upon metabolic oxidation of insecticide synergists of the 1,3-benzodioxole series.
J Am Chem Soc
101:
3971-3973
[CrossRef]
Murray M,
Wilkinson CF,
Marcus C,
Dubé CE
(1993)
Mol Pharmacol
24:
129-136
[Abstract]
Nagata T,
Nemoto Y,
Hasezawa S
(1992)
Tobacco BY-2 cell line as the "Hela" cell in the biology of higher plants.
Int Rev Cytol
132:
1-30
[ISI]
Omura R,
Sato R
(1964)
The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature.
J Biol Chem
239:
2370-2378
[Free Full Text]
Ortiz de Montellano PR, Correia MA (1995) Inhibition of cytochrome
P450 enzymes. In PR Ortiz de Montellano, ed, Cytochrome
P450: Structure, Mechanism, and Biochemistry, Ed 2. Plenum Press, New
York, pp 305-364
Pierrel MA,
Batard Y,
Kazmaier M,
Mignotte-Vieux C,
Durst F,
Werck-Reichhart D
(1994)
Catalytic properties of the plant cytochrome P450 CYP73 expressed in yeast: substrate specificity of a cinnamate hydroxylase.
Eur J Biochem
224:
835-844
[Medline]
Raag R,
Poulos TL
(1989)
The structural basis for substrate-induced changes in redox potential and spin equilibrium in cytochrome P450CAM.
Biochemistry
28:
917-922
[CrossRef][Medline]
Reichhart D,
Salaün JP,
Benveniste I,
Durst F
(1980)
Time course of induction of cytochrome P450, NADPH-cytochrome c reductase, and cinnamic acid hydroxylase by phenobarbital, ethanol, herbicides, and manganese in higher plant microsomes.
Plant Physiol
66:
600-604
[Abstract/Free Full Text]
Reichheld JP,
Sonobe S,
Clement B,
Chaubet N,
Gigot C
(1995)
Cell cycle-regulated histone gene expression in synchronized plant cells.
Plant J
7:
245-252
[CrossRef][ISI]
Schalk M,
Batard Y,
Seyer A,
Nedel'kina S,
Durst F,
Werck-Reichhart D
(1997)
Naphthoic acids, alternate fluorescent substrates or inhibitors of CYP73A1, a plant cinnamate 4-hydroxylase.
Biochemistry
36:
15253-15261
[CrossRef][Medline]
Schuler MA
(1996)
Plant cytochrome P450 monooxygenases.
Crit Rev Plant Sci
15:
235-284
Sewalt VJH,
Ni W,
Blount JW,
Jung HG,
Masoud SA,
Howles PA,
Lamb C,
Dixon RA
(1997)
Reduced lignin content and altered lignin composition in transgenic tobacco down-regulated in expression of L-phenylalanine ammonia-lyase or cinnamate 4-hydroxylase.
Plant Physiol
115:
41-50
[Abstract]
Silverman RB
(1996)
Mechanism-based enzyme inactivators.
In
DL Purich,
eds, Contemporary Enzyme Kinetics and Mechanism, Ed 2.
Academic Press, San Diego, pp 291-334
Tal B,
Robeson DJ
(1986)
Phytochemistry
25:
77-79
[CrossRef]
Teutsch GH,
Hasenfratz MP,
Lesot A,
Stoltz C,
Garnier JM,
Jeltsch JM,
Durst F,
Werck-Reichhart D
(1993)
Isolation and sequence of a cDNA encoding the Jerusalem artichoke cinnamate 4-hydroxylase, a major plant cytochrome P450 involved in the general phenylpropanoid pathway.
Proc Natl Acad Sci USA
90:
4102-4106
[Abstract/Free Full Text].
Truan G,
Collin C,
Reisdorf P,
Urban P,
Pompon D
(1993)
Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5.
Gene
125:
49-55
[CrossRef][ISI][Medline]
Urban P,
Werck-Reichhart D,
Teusch HG,
Durst F,
Mignotte C,
Katzmaier M,
Pompon D
(1994)
Characterization of a recombinant plant cinnamate 4-hydroxylase produced in yeast: kinetic and spectral properties of the major plant P450 of the phenylpropanoid pathway.
Eur J Biochem
222:
843-850
[ISI][Medline]
Varsano R,
Rabinovitch HD,
Rubin B
(1992)
Mode of action of piperonyl butoxide as herbicide synergist of atrazine and terbutryn in maize.
Pestic Biochem Physiol
44:
174-182
Werck-Reichhart D
(1995)
Cytochromes P450 in phenylpropanoid metabolism.
Drug Metab Drug Interact
12:
221-243
[Medline]
Werck-Reichhart D,
Gabriac B,
Teusch H,
Durst F
(1990)
Two cytochromes P450 isoforms catalyzing O-dealkylation of ethoxycoumarin and ethoxyresorufin in higher plants.
Biochem J
270:
719-735
Wilkinson CF,
Murray M,
Marcus CB
(1984)
Interactions of methylenedioxyphenyl compounds with cytochrome P450 and effects on microsomal oxidation.
In
E Hodgson,
JR Bend,
RM Philipot,
eds, Reviews in Biochemical Toxicology, Vol 6.
Elsevier, Amsterdam, The Netherlands, pp 27-63
Yalpani N,
León J,
Lawton MA,
Raskin I
(1993)
Pathway of salicylic acid biosynthesis in healthy and virus-inoculated tobacco.
Plant Physiol
103:
315-321
[Abstract]
Yu LH,
Wilkinson CF,
Anders M,
W
(1980)
Generation of carbon monoxide during the microsomal metabolism of methylenedioxyphenyl compounds.
Biochem Pharmacol
29:
1113-1122
[CrossRef][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
R. Menard, S. Alban, P. de Ruffray, F. Jamois, G. Franz, B. Fritig, J.-C. Yvin, and S. Kauffmann
{beta}-1,3 Glucan Sulfate, but Not {beta}-1,3 Glucan, Induces the Salicylic Acid Signaling Pathway in Tobacco and Arabidopsis
PLANT CELL,
November 1, 2004;
16(11):
3020 - 3032.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-K. Ro and C. J. Douglas
Reconstitution of the Entry Point of Plant Phenylpropanoid Metabolism in Yeast (Saccharomyces cerevisiae): IMPLICATIONS FOR CONTROL OF METABOLIC FLUX INTO THE PHENYLPROPANOID PATHWAY
J. Biol. Chem.,
January 23, 2004;
279(4):
2600 - 2607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Schoch, R. Attias, M. Belghazi, P. M. Dansette, and D. Werck-Reichhart
Engineering of a Water-Soluble Plant Cytochrome P450, CYP73A1, and NMR-Based Orientation of Natural and Alternate Substrates in the Active Site
Plant Physiology,
November 1, 2003;
133(3):
1198 - 1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Schoch, G. N. Nikov, W. L. Alworth, and D. Werck-Reichhart
Chemical Inactivation of the Cinnamate 4-Hydroxylase Allows for the Accumulation of Salicylic Acid in Elicited Cells
Plant Physiology,
October 1, 2002;
130(2):
1022 - 1031.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chong, M.-A. Pierrel, R. Atanassova, D. Werck-Reichhart, B. Fritig, and | |